With one year of operations now under its belt since the grand opening, pharma giant GlaxoSmithKline has a bold future planned for its research and development facility in Maryland.
PerkinElmer Inc. announced that it has entered into a definitive agreement to acquire EUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN.
Merck is globally committed to an antimicrobial stewardship encompassing surveillance, R&D, and health policy.
A molecule that carries the recipe for making drugs inside body cells is exciting scientists and investors alike, attracting hundreds of millions of dollars in a scramble for the next […]
Medivir AB (MVRBF), headquartered in Stockholm, Sweden, announced today that it will restructure its Discovery Research department, narrowing its focus to oncology and infectious diseases. In addition, it announced a […]